Skip to content
ESMO - Eur. Oncology· @myESMO · X·· 1 day agoScore70

CAPITELLO-281

Body · original

#ESMO26: Adding capivasertib to abiraterone and adding abiraterone to standard care resulted in significant improvements in #ProstateCancer in the phase III CAPItello-281 and PEACE-1 #ClinicalTrials, as discussed by Elena Castro

🔗 https://ow.ly/k8xU50ZZk08

#InsightsbyESMO

264 views · 0 likes · 0 reposts · 0 replies

Conference abstracts
LBA56NCT04746300matched by Rapid oral: Genitourinary tumours, prostate, penile and testis

Capivasertib (capi) + abiraterone (abi) vs placebo (pbo) + abi in patients (pts) with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC): Updated overall survival (OS) from CAPItello-281

https://esmocongress.esmo.org

Source: ESMO - Eur. Oncology · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org